Driving reinvestment in R&D for antibiotics and advocating their responsible use

DRIVE-AB is organizing high-level conference to identify and evaluate feasible reward models

The consortium is organizing a high-level conference to bring together policy makers, regulatory and public health experts, and economists to identify and evaluate reward models that are feasible, practical and can be implemented globally.

This event is expected to stimulate a dialogue among international decision-makers on the implementation of R&D incentive policies which will help to inform DRIVE-AB final recommendations, which will be announced in 2017.

For more information, please view the event page.